Welcome back! Today we're excited to be joined by Dr. Robert Schooley, an individual who many of you may recognize in the coming years as a leading pioneer in the development of bacteriophage medicine. His prior work includes and is far from limited to Co-Director of the Center for Innovative Phage Applications and Therapeutics at UCSD, head of NIAID's AIDS Clinical Trials team which produced many of the antiretrovirals still in use for HIV/AIDS, as well as Editor of the Journal of Clinical Infectious diseases. Our conversation covered the history of bacteriophages, their unique clinical utility as an efficient alternative to antibiotics, and their potential in a world with antibiotic resistance that threatens much of the progress of the last century.